Parabilis Medicines (PBLS) insider trading in the last 6 months
3 insiders bought $441M. No sales.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Form 4 filings, newest first
Who files at Parabilis Medicines
- Alan Sebulsky
Cluster buys at PBLS
3 insiders bought PBLS in the last 6 months: Ra Capital Management, L.P., Guy Levy, and Alan Sebulsky.
Questions about PBLS's insider trades
Are PBLS insiders buying or selling?
3 insiders bought $441M across 14 filings in the last 6 months. No open-market sales on record. The newest filing: Ra Capital Management, L.P., 10% owner, bought $2.7M on Jul 20, 2026. 3 insiders bought PBLS in the last 6 months: Ra Capital Management, L.P., Guy Levy, and Alan Sebulsky.
Who are PBLS's biggest insider sellers?
No PBLS insider sold shares on the open market in the last 6 months, as filed on Form 4.
When did a PBLS insider last buy?
Ra Capital Management, L.P., 10% owner, bought PBLS shares ($2.7M) on Jul 20, 2026, filed Jul 22, 2026, the newest insider buy on record.
Parabilis Medicines's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.